Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Minority Interest (2020 - 2025)

ImmunityBio (IBRX) has disclosed Minority Interest for 6 consecutive years, with $895000.0 as the latest value for Q4 2025.

  • Quarterly Minority Interest fell 7.64% to $895000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $895000.0 through Dec 2025, down 7.64% year-over-year, with the annual reading at $895000.0 for FY2025, 7.64% down from the prior year.
  • Minority Interest for Q4 2025 was $895000.0 at ImmunityBio, down from $909000.0 in the prior quarter.
  • The five-year high for Minority Interest was $1.1 million in Q3 2023, with the low at -$3.1 million in Q2 2023.
  • Average Minority Interest over 5 years is -$416450.0, with a median of $673000.0 recorded in 2021.
  • The sharpest move saw Minority Interest crashed 523.95% in 2022, then skyrocketed 145.0% in 2023.
  • Over 5 years, Minority Interest stood at -$1.7 million in 2021, then tumbled by 43.28% to -$2.5 million in 2022, then skyrocketed by 142.12% to $1.0 million in 2023, then decreased by 7.71% to $969000.0 in 2024, then decreased by 7.64% to $895000.0 in 2025.
  • According to Business Quant data, Minority Interest over the past three periods came in at $895000.0, $909000.0, and $930000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.